Since the 1990s, bed nets with insecticides have been an invaluable tool for malaria prevention, wrote Gretchen Vogel with Science.org on February 2, 2022.
While young children who sleep under these nets are far less likely to die of the disease, some scientists have worried this might increase the risk of contracting malaria later in life by preventing the development of natural immunity.
Now, an ambitious new study’s finding allays those fears.
Malaria Prevention Includes Protective Sleeping
Low-Dose Ivermectin Found Ineffective with High-Risk COVID-19 Patients
The peer-reviewed JAMA Network published a study today that found in a randomized clinical trial of high-risk patients with mild to moderate COVID-19, ivermectin treatment during early illness did not prevent progression to severe disease.
This study’s findings, published on February 18, 2022, do not support the use of low-dose ivermectin for COVID-19 patients at risk.
These 500 randomized COVID-19 patients received Ivermectin 0.4mg/kg of body weight/day for 5 days.
Recommended Adult Immunization Schedule Updated for 2022
Changes include universal vaccination against hepatitis B for all adults aged 19 through 59 years and for at-risk older adults
Baricitinib Reduces Mortality in Critically Ill Adults With COVID-19
Reduction in death seen at 28, 60 days for patients receiving invasive mechanical ventilation, extracorporeal membrane oxygenation
Poor Outcomes Common With COVID-19, Acute Ischemic Stroke
Factors associated with poor functional outcomes included age older than 60 years, diabetes mellitus, increased NIHSS, LVO
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Feb. 14 to 18, 2022. This …
Scientists Report ‘Rogue Antibodies’ Behind Severe Clotting With COVID-19
Study authors suggest future research assess the potential benefits of screening COVID-19 patients for antiphospholipids and other autoantibodies